首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma
【24h】

Inhibition of sonic hedgehog signaling blocks cell migration and growth but induces apoptosis via suppression of FOXQ1 in natural killer/T-cell lymphoma

机译:抑制声波刺猬信号传导细胞迁移和生长,但通过抑制自然杀伤/ T细胞淋巴瘤抑制FoxQ1的细胞凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Highlights ? It was firstly investigated the underlying mechanism of FOXQ1 in NKTCL. ? FOXQ1 mRNA was significantly higher in NKTCL patients than healthy controls. ? FOXQ1 was related to Ann Arbor stage, bone marrow involvement and prognosis of NKTCL patients. ? Inhibiting FOXQ1 suppressed NKTCL cell growth and induced apoptosis by blocking Shh pathway. Abstract The present study explored the effects of Forkhead box Q1 (FOXQ1) on cell proliferation, cell cycle and apoptosis via the Sonic hedgehog (Shh) pathway in Natural killer/T-cell lymphoma (NKTCL). Quantitative real time-polymerase chain reaction (qRT-PCR) was performed to detect FOXQ1 expression in 117 NKTCL patients and 120 healthy controls. Additionally, FOXQ1 expression in NKTCL cell lines (HANK-1, NK-92, SNK-6, SNT-8 and YT) was determined by western blotting and qRT-PCR. SNK-6 cells were transfected with FOXQ1-shRNA or Shh pathway inhibitor Cyclopamine/recombinant protein Shh. Cell counting kit-8 (CCK-8) and 5-bromo-2-deoxy-uridine (BrdU) incorporation assays were conducted to detect cell proliferation, flow cytometry was used to determine the cell cycle and cell apoptosis, and western blotting was used to detect protein expression. FOXQ1 expression was higher in NKTCL patients than in healthy controls, which was related to Ann Arbor stage, bone marrow involvement and the 5year survival rate in NKTCL patients. Moreover, FOXQ1 expression, pathological type, Ann Arbor stage, B symptom and bone marrow involvement were independent risk factors in NKTCL. Shh pathway-related proteins were down-regulated after transfection of SNK-6 cells with FOXQ1-shRNA. Additionally, SNK-6 cell proliferation was greatly reduced, the cell cycle was blocked at the G0/G1 phase, and the expression of CyclinD1 and CyclinE was markedly decreased, while an increase in cell apoptosis with elevated Bcl-2-associated X protein (Bax) and Caspase-3 and reduced B-cell lymphoma/leukemia-2 (Bcl-2) were also observed. However, no significant alterations were observed between the FOXQ1-shRNA+Shh and Blank groups. The inhibition of FOXQ1 restricted NKTCL cell proliferation and growth but induced apoptosis via blocking the Shh signaling pathway.
机译:强调 ?首先调查了NKTCL中FoxQ1的潜在机制。还NKTCL患者的FoxQ1 mRNA显着高于健康的对照。还FoxQ1与NKTCL患者的骨髓参与和预后有关。还抑制FoxQ1抑制NKTCL细胞生长并通过阻断SHH途径诱导细胞凋亡。摘要本研究探讨了FORKHEAD盒Q1(FOXQ1)对通过天然杀伤/ T细胞淋巴瘤(NKTCL)的Sonic Hedgehog(SHH)途径的细胞增殖,细胞周期和细胞凋亡的影响。进行定量实时 - 聚合酶链反应(QRT-PCR)以检测117名NKTCL患者和120例健康对照中的FoxQ1表达。另外,通过蛋白质印迹和QRT-PCR测定NKTCL细胞系(Hank-1,NK-92,SNK-6,SNT-8和YT)中的FoxQ1表达。用FoxQ1-shRNA或SHH途径抑制剂环丙胺/重组蛋白SHH转染SNK-6细胞。进行细胞计数试剂盒-8(CCK-8)和5-溴-2-脱氧 - 尿苷(BRDU)掺入测定以检测细胞增殖,流式细胞术用于确定细胞周期和细胞凋亡,并使用蛋白质印迹检测蛋白质表达。 NKTCL患者的福氏菌表达高于健康对照,其与Ann Arbor阶段,骨髓受累和NKTCL患者的5年生存率有关。此外,FoxQ1表达,病理型,Ann arbor阶段,B症状和骨髓受累是NKTCL中的独立风险因素。用FoxQ1-ShRNA转染SNK-6细胞后,SHH途径相关蛋白质下调。此外,SNK-6细胞增殖大大降低,细胞周期在G0 / G1相中封闭,Cyclind1和环曲线的表达明显降低,而具有升高的Bcl-2相关X蛋白的细胞凋亡增加(还观察到BAX)和Caspase-3和降低的B细胞淋巴瘤/白血病-2(BCL-2)。然而,在FoxQ1-shRNA + Shh和空白组之间没有观察到显着改变。抑制FoxQ1限制NKTCL细胞增殖和生长,但通过阻断SHH信号通路诱导细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号